Advertisement

“Cardioprotection” — Not all calcium antagonists are created equal

  • Franz H. Messerli
    Correspondence
    Address for reprints: Franz H. Messerli, MD, Ochsner Clinic, 1514 Jefferson Highway, New Orleans, Louisiana 70121.
    Affiliations
    From the Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fleckenstein A
        Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the production or prevention of myocardial lesions.
        in: Harris P Opie L Calcium and the Heart. Proceedings of the Meeting of the European Section of the International Study Group for Research in Cardiac Metabolism. Academic Press, New York1970: 135-188
        • Nayler WG
        • Grau A
        • Slade A
        A protective effect of verapamil on hypoxic heart muscle.
        Cardiovasc Res. 1976; 10: 650-662
        • Fleckenstein A
        History of calcium antagonists.
        Circ Res. 1983; 52: 3-16
        • Nagao T
        • Matlib MA
        • Franklin D
        • Millard RW
        • Schwartz A
        Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion.
        J Mol Cell Cardiol. 1980; 12: 29-43
        • Kober G
        • Schneider W
        • Kaltenbach M
        Can the progression of coronary sclerosis be influenced by calcium antagonists?.
        J Cardiovasc Pharmacol. 1989; 13: S2-S6
        • Lichtlen PR
        • Hugenholtz PG
        • Rafflenbeul W
        • Hecker H
        • Jost S
        • Deckers JW
        • The INTACT Group Investigators
        Retardation of angiographic progression of coronary artery disease by nifedipine.
        Lancet. 1990; 335: 1109-1113
        • Held PH
        • Yusuf S
        • Furberg CD
        Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
        Br Med J. 1989; 299: 1187-1192
        • Lublin JS
        Calcium channel blockers called ineffective against heart disease. Review of 28 studies claims the drugs can't prevent either attacks or deaths.
        The Wall Street Journal. November 10, 1989; B4
        • Hlatky MA
        • Cotugno HE
        • Mark DB
        • O'Connor C
        • Califf R
        Trends in physician management of uncomplicated acute infarction, 1970 to 1987.
        Am J Cardiol. 1988; 61: 515-518
        • The Danish Study Group on Verapamil in Myocardial Infarction
        The effect of verapamil on mortality and major events after myocardial infarction. The Danish verapamil infarction trial II (DAVIT II).
        Am J Cardiol. 1990; 66: 779-785
        • The Danish Study Group on Verapamil in Myocardial Infarction
        Verapamil in acute myocardial infarction.
        Eur Heart J. 1984; 5: 516-528
        • The Multicenter Diltiazem Postinfarction Trial Research Group
        The effect of diltiazem on mortality and reinfarction after myocardial infarction.
        N Engl J Med. 1988; 319: 385-392
        • Gibson RS
        • Boden WE
        • Theroux P
        • Strauss HD
        • Pratt CM
        • Gheorghiade M
        • Capone RJ
        • Crawford MH
        • Schlant RC
        • Kleiger RE
        • Young PM
        • Schechtman K
        • Perryman MB
        • Roberts R
        • The Diltiazem Reinfarction Study Group
        Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized multicenter trial.
        N Engl J Med. 1986; 315: 423-429
        • Moss AJ
        • Rubison M
        • Oakes D
        • Carleen E
        • Eberly S
        • Brown M
        • The Multicenter Diltiazem Postinfarction Trial (MDPIT) Research Group
        Effect of diltiazem on long-term outcome in post-infarction patients with a history of hypertension (abstr).
        Circulation. 1989; 80: II
        • Moss AJ
        • Rubison M
        • Oakes D
        • Carleen E
        • Eberly S
        • Brown M
        • The Multicenter Diltiazem Postinfarction Trial (MDPIT) Research Group
        Effect of diltiazem on long-term outcome in post-infarction patients with a history of hypertension (abstr).
        Circulation. 1989; 80: II-268